J Clin Oncol 26 (1): 44-53, 2008.[PUBMED Abstract] Henderson IC, Berry DA, Demetri GD, et al.: Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.
J Clin Oncol 21 (6): 976-83, 2003.[PUBMED Abstract] Mamounas EP, Bryant J, Lembersky B, et al.: Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28.
J Clin Oncol 23 (16): 3686-96, 2005.[PUBMED Abstract] Martin M, Pienkowski T, Mackey J, et al.: Adjuvant docetaxel for node-positive breast cancer.